Veeva Systems Inc. $VEEV Shares Purchased by Odyssean LLC

Odyssean LLC raised its stake in shares of Veeva Systems Inc. (NYSE:VEEV) by 144.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 18,634 shares of the technology company’s stock after acquiring an additional 10,997 shares during the quarter. Veeva Systems makes up 0.5% of Odyssean LLC’s portfolio, making the stock its 16th biggest position. Odyssean LLC’s holdings in Veeva Systems were worth $3,307,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently added to or reduced their stakes in VEEV. Principal Financial Group Inc. lifted its position in shares of Veeva Systems by 7.0% during the first quarter. Principal Financial Group Inc. now owns 4,141,545 shares of the technology company’s stock worth $727,513,000 after purchasing an additional 271,252 shares during the last quarter. State Street Corp increased its holdings in Veeva Systems by 2.4% in the fourth quarter. State Street Corp now owns 3,589,425 shares of the technology company’s stock valued at $801,267,000 after buying an additional 85,695 shares during the last quarter. Geode Capital Management LLC increased its holdings in Veeva Systems by 0.7% in the fourth quarter. Geode Capital Management LLC now owns 3,172,716 shares of the technology company’s stock valued at $706,442,000 after buying an additional 23,117 shares during the last quarter. AQR Capital Management LLC raised its stake in Veeva Systems by 31.2% during the third quarter. AQR Capital Management LLC now owns 2,412,210 shares of the technology company’s stock valued at $706,078,000 after buying an additional 574,164 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Veeva Systems by 12.3% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,728,089 shares of the technology company’s stock valued at $385,761,000 after buying an additional 189,093 shares in the last quarter. 88.20% of the stock is owned by institutional investors and hedge funds.

Key Headlines Impacting Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Major Vault CRM customer wins strengthen Veeva’s competitive position. Biogen and Regeneron each committed to Veeva Vault CRM globally. The agreements support adoption of Veeva’s unified, AI-enabled commercial platform and provide further evidence of traction in the biopharmaceutical market. Veeva Vault CRM Selected by Biogen Veeva Vault CRM Selected by Regeneron
• Positive Sentiment: Truist said the wins reinforce Vault CRM’s market-leader status ahead of earnings. The analyst view suggests the customer additions could support future bookings, recurring revenue growth and broader cross-selling across Veeva’s life-sciences cloud products. Veeva’s Vault CRM Wins Reinforce Market-Leader Status Ahead of Earnings, Truist Says
• Positive Sentiment: Analyst sentiment remains favorable. Piper Sandler initiated coverage with an Overweight rating and a $295 price target, while Needham reiterated its Buy rating with a $270 target. Both targets imply additional upside from the referenced share price.
• Neutral Sentiment: Earnings are the immediate catalyst. Investors are looking for continued double-digit growth driven by Vault CRM, Falcon AI and R&D Cloud. The company’s latest reported quarter showed 16.3% year-over-year revenue growth and an earnings beat, raising expectations for another solid performance. What To Expect From Veeva Systems’s Q2 Earnings
• Negative Sentiment: Valuation leaves limited room for disappointment. Veeva trades at roughly 44 times earnings after a substantial rally, so any weakness in guidance, bookings or operating trends could prompt profit-taking. The stock’s decline ahead of results likely reflects investor caution while the market awaits confirmation of growth expectations.

Wall Street Analyst Weigh In

Several research analysts have recently commented on VEEV shares. Barclays lifted their target price on Veeva Systems from $235.00 to $275.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 18th. Canaccord Genuity Group dropped their price target on Veeva Systems from $235.00 to $220.00 and set a “hold” rating on the stock in a research report on Thursday, June 4th. BMO Capital Markets reduced their price objective on Veeva Systems from $220.00 to $175.00 and set a “market perform” rating on the stock in a research note on Thursday, June 4th. BTIG Research reaffirmed a “buy” rating and issued a $340.00 price objective on shares of Veeva Systems in a report on Thursday, June 4th. Finally, UBS Group lowered their target price on shares of Veeva Systems from $220.00 to $190.00 and set a “neutral” rating for the company in a research note on Thursday, June 4th. Nineteen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $258.08.

Veeva Systems Stock Down 0.4%

Shares of VEEV stock opened at $247.38 on Wednesday. The company has a market cap of $40.18 billion, a P/E ratio of 44.10, a PEG ratio of 1.07 and a beta of 0.92. The business has a 50 day moving average of $201.60 and a two-hundred day moving average of $182.61. Veeva Systems Inc. has a 52 week low of $148.05 and a 52 week high of $310.50.

Veeva Systems (NYSE:VEEV) last announced its quarterly earnings results on Wednesday, June 3rd. The technology company reported $2.24 earnings per share for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. The business had revenue of $882.95 million for the quarter, compared to analysts’ expectations of $857.73 million. Veeva Systems had a return on equity of 13.72% and a net margin of 28.37%.The business’s quarterly revenue was up 16.3% on a year-over-year basis. During the same period in the prior year, the firm earned $1.97 EPS. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. Analysts expect that Veeva Systems Inc. will post 6.64 EPS for the current fiscal year.

Insider Buying and Selling

In other Veeva Systems news, insider Thomas D. Schwenger sold 36,000 shares of the stock in a transaction on Thursday, August 13th. The stock was sold at an average price of $250.23, for a total value of $9,008,280.00. Following the sale, the insider directly owned 19,449 shares of the company’s stock, valued at $4,866,723.27. This trade represents a 64.92% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is currently owned by insiders.

Veeva Systems Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.